1. Home
  2. TRDA vs EHAB Comparison

TRDA vs EHAB Comparison

Compare TRDA & EHAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRDA
  • EHAB
  • Stock Information
  • Founded
  • TRDA 2016
  • EHAB 2014
  • Country
  • TRDA United States
  • EHAB United States
  • Employees
  • TRDA N/A
  • EHAB N/A
  • Industry
  • TRDA Biotechnology: Pharmaceutical Preparations
  • EHAB Hospital/Nursing Management
  • Sector
  • TRDA Health Care
  • EHAB Health Care
  • Exchange
  • TRDA Nasdaq
  • EHAB Nasdaq
  • Market Cap
  • TRDA 336.6M
  • EHAB 401.6M
  • IPO Year
  • TRDA 2021
  • EHAB N/A
  • Fundamental
  • Price
  • TRDA $8.38
  • EHAB $10.26
  • Analyst Decision
  • TRDA Strong Buy
  • EHAB Hold
  • Analyst Count
  • TRDA 3
  • EHAB 3
  • Target Price
  • TRDA $25.67
  • EHAB $8.50
  • AVG Volume (30 Days)
  • TRDA 139.5K
  • EHAB 291.4K
  • Earning Date
  • TRDA 05-08-2025
  • EHAB 05-07-2025
  • Dividend Yield
  • TRDA N/A
  • EHAB N/A
  • EPS Growth
  • TRDA N/A
  • EHAB N/A
  • EPS
  • TRDA 0.61
  • EHAB N/A
  • Revenue
  • TRDA $172,220,000.00
  • EHAB $1,032,300,000.00
  • Revenue This Year
  • TRDA N/A
  • EHAB $5.33
  • Revenue Next Year
  • TRDA N/A
  • EHAB $4.86
  • P/E Ratio
  • TRDA $14.69
  • EHAB N/A
  • Revenue Growth
  • TRDA 5.74
  • EHAB N/A
  • 52 Week Low
  • TRDA $7.10
  • EHAB $6.85
  • 52 Week High
  • TRDA $21.79
  • EHAB $10.70
  • Technical
  • Relative Strength Index (RSI)
  • TRDA 43.04
  • EHAB 79.60
  • Support Level
  • TRDA $7.71
  • EHAB $7.89
  • Resistance Level
  • TRDA $9.46
  • EHAB $8.12
  • Average True Range (ATR)
  • TRDA 0.60
  • EHAB 0.32
  • MACD
  • TRDA 0.05
  • EHAB 0.27
  • Stochastic Oscillator
  • TRDA 38.29
  • EHAB 97.46

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.

About EHAB Enhabit Inc.

Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services to adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing an advanced, life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.

Share on Social Networks: